Clinical Trial Update: Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of topotecan and vinorelbine in patients with recurrent lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Topotecan (topotecan)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED